Other languages Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-21 am EDT			5-day change	1st Jan Change
309 ^JPY	-8.85%		-25.18%	-33.69%

May. 09	Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd.	CI
May. 07	Profit-Taking, China Outlooks Churn Asian Stock Markets	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poxel : un chiffre d'affaires trimestriel de 449000 euros	May. 17
Profit-Taking, China Outlooks Churn Asian Stock Markets	May. 07
Fed Outlook, Earnings Season Roil Asian Stock Markets	May. 02
Sumitomo Pharma Sees Impairment Losses and Restructuring Expenses in Fiscal 2024	May. 02
Sumitomo Pharma Expects Substantial Valuation Loss on Subsidiary Shares; Assures No Impact on Consolidated Profit	May. 02
Poxel : reporte la publication de ses résultats annuels 2023	Apr. 29
Lull in Geopolitical Tensions Lifts Asian Stock Markets	Apr. 22
Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	Apr. 02
Roivant's anti-inflammatory drug succeeds in mid-stage study	Apr. 02
Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	Mar. 15
US Inflation Report Lifts Asian Stock Markets	Mar. 01
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	Feb. 16
Japan's Nikkei slips after Fed chair signals delay in rate cut	Jan. 31
Sumitomo Pharma Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Jan. 31
Sumitomo Pharma Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	Jan. 31
Fed, China Property Outlooks Roil Asian Stock Markets	Jan. 30
Japan's Nikkei rounds off 2023 with biggest yearly gain in a decade	Dec. 29
Interest Rates, China Housing Measures Lift Asian Stock Markets	Dec. 15
China Real Estate, FX Roil Asian Stock Markets	Nov. 29
Gedeon Richter Plc., Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH Receives European Commission grant for Commercialisation of RYEQO®	Nov. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Other languages

Filters